Andrew Lo
CIK 1679076 · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.33M
Companies
6
Total Filings
35
Lifetime Open-Market Net
$72.40M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 68,662 | $85.55 | $5.87M | -$10.07M | 10 | 2026-06-24 |
| ABCL | Director | 86,938 | $5.29 | $459.9K | $1.22M | 5 | 2025-06-16 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 52,142 | $2.75 | $143.4K | $0 | 1 | 2022-09-19 |
| Urovant Sciences Ltd. (UROV) Delisted | 10%+ Owner | 22,860,013 | $16.24 | $371.25M | $38.75M | 9 | 2019-06-19 |
| Myovant Sciences Ltd. (MYOV) Delisted | 10%+ Owner | 40,765,599 | $26.98 | $1.10B | $42.50M | 2 | 2019-06-06 |
| ABUS | 10%+ Owner | — | $4.41 | — | $0 | 2 | 2018-01-16 |
Recent Filings · Page 2 of 4
35 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-23 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2022-12-05 | ABCL | Grant (A) | — | $0 | EDGAR |
| 2022-09-19 | Roivant Sciences Ltd. (ROIVW) Delisted | Grant (A) | +52,142 | $0 | EDGAR |
| 2022-06-24 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2022-01-03 | BBIO | Buy (P) | +7,500 | $98.8K | EDGAR |
| 2021-12-10 | ABCL | Grant (A) | — | $0 | EDGAR |
| 2021-12-07 | ABCL | Buy (P) | +86,938 | $1.22M | EDGAR |
| 2021-06-22 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2019-06-19 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +18,204 | $151.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.